A Gene Delivery Study to Evaluate the Safety and Expression of Delandistrogene Moxeparvovec in Participants Under the Age of Four With Duchenne Muscular Dystrophy (DMD)

Conditions: Duchenne Muscular Dystrophy Interventions: Genetic: delandistrogene moxeparvovec Sponsors: Hoffmann-La Roche; Sarepta Therapeutics, Inc. Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials